Performance analysis of Novavax (NVAX)
Annual Return
Over the past 3 years, NVAX has had an average annual return of -0.33%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, NVAX has had an average annual return of -47.90%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, NVAX has had an average annual return of -25.20%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 1, 1999, NVAX has had an average annual return of -8.98%, underperforming the benchmark SPY, which returned +8.49% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +20.09% | -16.42% | +67.50% | -53.31% | -92.81% | +28.30% | +2,701.76% | -89.18% | +48.39% | -1.59% | -84.98% | +41.48% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| +15.82% | +170.90% | +50% | -48.15% | -8.65% | +40.74% | -43.24% | -18.78% | +6.49% | +18.10% | -45.67% | +130.77% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -81.56% | +65.88% | +51.25% | +12.40% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +31.70% | +14.58% | -19.72% | -2.58% | +38.34% | -14.13% | -14.33% | +20.09% | |||||
| 2025 | +8.08% | -4.14% | -23.05% | +4.06% | +10.04% | -14.17% | +5.56% | +12.33% | +16.06% | -3.11% | -16.07% | -4.68% | -16.42% |
| 2024 | -16.67% | +23.50% | -3.24% | -9.41% | +247.11% | -15.77% | +1.18% | -3.36% | +2.02% | -23.91% | -9.26% | -7.80% | +67.50% |
| 2023 | +6.13% | -15.12% | -25.16% | +10.68% | +4.95% | -7.70% | +24.90% | -13.79% | -9.50% | -8.01% | -17.42% | -12.73% | -53.31% |
| 2022 | -34.51% | -11.02% | -11.66% | -38.81% | +22.76% | -7.05% | +5.99% | -39.39% | -44.92% | +22.36% | -25.95% | -37.66% | -92.81% |
| 2021 | +98.13% | +4.66% | -21.59% | +30.68% | -37.69% | +43.82% | -15.53% | +33.02% | -13.09% | -28.21% | +40.18% | -31.42% | +28.30% |
| 2020 | +91.46% | +109.97% | -15.12% | +33.51% | +153.94% | +81.04% | +71.69% | -22.89% | -1.80% | -25.51% | +72.84% | -20.06% | +2,701.76% |
| 2019 | +27.17% | -69.87% | -21.84% | -3.54% | -46.57% | +3.17% | -26.45% | +38.52% | -15.91% | -16.93% | +16.31% | -17.94% | -89.18% |
| 2018 | +62.90% | +7.43% | -3.23% | -25.71% | +4.49% | -17.79% | -5.22% | +22.83% | +20.51% | -6.38% | +17.61% | -11.11% | +48.39% |
| 2017 | +3.97% | +15.27% | -15.23% | -36.25% | +12.93% | +24.80% | -9.57% | +0.96% | +8.57% | -4.39% | +24.77% | -8.82% | -1.59% |
Drawdown analysis of Novavax (NVAX)
The maximum drawdown for the NVAX was -98.82%, occurring on Feb 5, 2024. This drawdown has not yet recovered.
The current NVAX drawdown is -97.48%.
Since Nov 1, 1999 NVAX has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.82% | Feb 8, 2021 | 752 | Feb 5, 2024 | Ongoing | Ongoing | Ongoing |
| -98.77% | Oct 9, 2001 | 4561 | Nov 20, 2019 | 305 | Feb 8, 2021 | 4866 |
| -58.91% | Mar 8, 2000 | 32 | Apr 24, 2000 | 323 | Aug 3, 2001 | 355 |
| -28.27% | Sep 10, 2001 | 5 | Sep 21, 2001 | 8 | Oct 3, 2001 | 13 |
| -18.43% | Nov 5, 1999 | 18 | Dec 2, 1999 | 10 | Dec 16, 1999 | 28 |
| -12.63% | Dec 17, 1999 | 19 | Jan 14, 2000 | 3 | Jan 20, 2000 | 22 |
| -10.34% | Jan 21, 2000 | 1 | Jan 24, 2000 | 11 | Feb 8, 2000 | 12 |
| -8.57% | Aug 22, 2001 | 3 | Aug 27, 2001 | 9 | Sep 10, 2001 | 12 |
| -8.06% | Feb 11, 2000 | 3 | Feb 16, 2000 | 9 | Mar 1, 2000 | 12 |
| -6.68% | Mar 6, 2000 | 1 | Mar 7, 2000 | 1 | Mar 8, 2000 | 2 |
| -5.02% | Oct 3, 2001 | 1 | Oct 4, 2001 | 3 | Oct 9, 2001 | 4 |
| -3.72% | Aug 6, 2001 | 2 | Aug 8, 2001 | 1 | Aug 9, 2001 | 3 |
| -2.91% | Aug 13, 2001 | 4 | Aug 17, 2001 | 3 | Aug 22, 2001 | 7 |
| -1.86% | Mar 2, 2000 | 1 | Mar 3, 2000 | 1 | Mar 6, 2000 | 2 |